高催吐风险化疗相关论文
目的:评估第一代与第二代5-羟色胺3受体拮抗剂(5-hydroxytryptamine 3 receptor antagonist,5-HT3RA)分别联合地塞米松(Dexamethas......
目的探讨应用品管圈在降低患者高催吐风险化疗所致恶心呕吐发生率(chemotherapy induced nausea and vomiting,CINV)中的影响。方......